Wizemann V, Timio M, Alpert M A, Kramer W
Georg-Haas Dialysis Center, Geissen, Germany.
Kidney Int Suppl. 1993 Feb;40:S85-91.
Most patients receiving renal replacement therapy have cardiovascular disease. The most frequent conditions are left ventricular hypertrophy and coronary artery disease. Hemodialysis is associated with a characteristic spectrum of acute complications (such as hypotension, sudden death) that can be explained by typical dialysis-induced effects on the heart. With continuous ambulatory peritoneal dialysis (CAPD) some of those cardiovascular complications are ameliorated due to slow ultra-filtration and absence of an arteriovenous fistula. It is concluded that CAPD might be the preferable option in patients with cardiovascular disease when hemodialysis can only be performed in a standardized and often aggressive manner. However, achievement of medically-defined goals appears to be more important than technique in dialysis therapy.
大多数接受肾脏替代治疗的患者患有心血管疾病。最常见的病症是左心室肥厚和冠状动脉疾病。血液透析与一系列典型的急性并发症（如低血压、猝死）相关，这些并发症可由透析对心脏产生的典型影响来解释。对于持续性非卧床腹膜透析（CAPD），由于超滤缓慢且不存在动静脉瘘，一些心血管并发症得到了改善。得出的结论是，当只能以标准化且通常较为激进的方式进行血液透析时，CAPD可能是心血管疾病患者的更优选择。然而，在透析治疗中，实现医学定义的目标似乎比技术更为重要。
